ALIVECOR INC.

Company Snapshot

Founded: 2010
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 444 Castro Street, 6th Floor, Mountain View, California 94041 U.S. Tel. +1-855-338-8800 www.alivecor.com

Company Overview

AliveCor Inc. develops personal digital devices for cardiac care. The company provides personal ECG devices for cardiac diseases. An FDA cleared ECG technology is enabled with AI, cloud and micro-electrode technology. AliveCor’s platform is developed using its proprietary deep neural network that analyzes ECG data to measure a user’s potassium levels without requiring blood from the patient. The company’s Kardia devices are available to customers in over 37 countries.

ALIVECOR INC. In Reports

Digital Biomarkers: Global Markets

BCC Research Market Analyst says global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030.

Digital Biomarkers: Global Markets

Global market for digital biomarkers should grow from $1.8 billion in 2021 to $7.2 billion by 2026, at CAGR of 31.6% for the period of 2021-2026.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

BCC Research Market Report for Chronic Disease Management. Global Chronic Disease Management market trends, with CAGRs through 2026.

Company's Business Segments

  • Cardiological Care : This segment includes KardiaMobile Card, KardiaMobile 6L, KardiaCare, where these tools help patients access, manage and share their data, and connect with cardiologists to better understand and manage their heart health.

Applications/End User Industries

  • Cardiology
  • Meachine Learning
  • Artificial Intelligence
  • Tachycardia
  • Bradycardia
  • Healthcare
  • Pharmaceutical
  • Medical Devices
  • Digital Healthcare
  • ECG Sensors
  • Life Sciences
AI Sentiment